Journal of Thoracic Oncology:
Clinicopathological Characteristics of Screen-Detected Lung Cancers: Erratum
In the article that appeared on page 615 of the May 2009 issue of the Journal of Thoracic Oncology, several errors have been identified. These errors appeared in the Abstract as well as the text. The data should have matched below. The new data is in bold for emphasis only. These errors have been noted in the online version of the article at www.jto.org.
Patients were classified into three groups according to the method of detection: SCR (n=1279), symptom-detected (SYM, n=466), and incidental (INC, n=536).
The 5-year survival rates in SCR, SYM, and INC group were 79.6%, 64.6%, and 74.6%, respectively.
Survival According to the Method of Detection: The 5-year survival rates in SCR, SYM, and INC group were 79.6%, 64.6%, and 74.6%, respectively.
SCR lung cancers were not only smaller (2cm or less in diameter: 42.6%) and at a lower stage (pathologic stage I: 70.8%), but also more often adenocarcinoma (85.8%) than SYM lung cancers.
In particular, such findings were more evident with CT in the SCR group (2cm or less in diameter: 76.4%, pathologic stage I: 92.6%, and adenocarcinoma: 92.6%).
Kawachi R, Watanabe S, Asamura H. Clinicopathological Characteristics of Screen-Detected Lung Cancers. J Thorac Oncol. 2009;4:615-619. View Full Text | PubMed